Export 503 results:
Autore Titolo Tipo [ Anno(Asc)]
Filtri: First Letter Of Last Name è Z  [Clear All Filters]
2011
Crovella S, Segat L, Amato A, Athanasakis E, Bezzerri V, Braggion C, Casciaro R, Castaldo G, Colombo C, Covone AElvira, De Rose V, Gagliardini R, Lanzara C, Minicucci L, Morgutti M, Nicolis E, Pardo F, Quattrucci S, Raia V, Ravazzolo R, Seia M, Stanzial V, Termini L, Zazzeron L, Cabrini G, Gasparini P. A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients. Clin Chem Lab Med 2011;49(1):49-54.
Secchiero P, Bosco R, Celeghini C, Zauli G. Recent advances in the therapeutic perspectives of Nutlin-3. Curr Pharm Des 2011;17(6):569-77.
Comar M, Zanotta N, Rossi T, Pelos G, D'Agaro P. Secondary lymphoid tissue as an important site for WU polyomavirus infection in immunocompetent children. J Med Virol 2011;83(8):1446-50.
Zampieri S, Buratti E, Dominissini S, Montalvo ALisa, Pittis MGabriela, Bembi B, Dardis A. Splicing mutations in glycogen-storage disease type II: evaluation of the full spectrum of mutations and their relation to patients' phenotypes. Eur J Hum Genet 2011;19(4):422-31.
Barbi E, Berti I, Minute M, Zennaro F. Successful treatment of acne with isotretinoin in chronic granulomatous disease. Eur J Dermatol 2011;21(1):111-2.
Corallini F, Celeghini C, Rimondi E, di Iasio MGrazia, Gonelli A, Secchiero P, Zauli G. Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. J Cell Physiol 2011;226(9):2279-86.
Sancilio S, Di Giacomo V, Quaglietta AM, Iacone A, Angelucci D, Tatasciore U, Rana RA, Cataldi A, Zauli G, Di Pietro R. TRAIL promotes a pro-survival signal in erythropoietin-deprived human erythroblasts through the activation of an NF-kB/IkBalpha pathway. J Biol Regul Homeost Agents 2011;25(3):375-86.

Amministrazione Trasparente